Proton Pump Inhibitors: How Safe is Long Usage of Pantoprazole?
Journal Title: Гастроентерологія - Year 2013, Vol 3, Issue 49
Abstract
The article deals with the approaches to treatment of acid-related diseases, there was determined key role of proton pump inhibitors. The special attention was given to safety of long usage of proton pump inhibitors, there were analyzed the findings of investigations regarding their influence on the state of gastroduodenal zone. The findings of research showing the safety of long-term treatment with pantoprazole during 15 years were considered in detail.
Authors and Affiliations
Yu. M. Stepanov, I. Ya. Budzak
Keywords
Related Articles
- EP ID EP231845
- DOI -
- Views 63
- Downloads 0
The Functional State of the Stomach and Immunological Resistance in Infants
The article presents the results of a study of the functional state of the stomach, nonspecific resistance indices and microbial intestinal colonization in neonates and young infants. It is found that in the first months...
Features of Chronic Pancreatitis in Transcarpathia
In the article the analysis of prevalence and incidence parameters for pancreatic diseases, digestive diseases in the general population in Transcarpathia has been carried out. The features of chronic pancreatic diseases...
Assessment of Quality of Life in Patients with Combination of Nonalcoholic Fatty Liver Disease and Stable Forms of Coronary Heart Disease
The article presents the results of assessment of the quality of life in patients with isolated nonalcoholic fatty liver disease and in combination with stable forms of coronary heart disease. Quality of life was evaluat...
Resistin as a Marker of Liver Function Disorder in Combined Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
The objective of the study — to assess the correlation between resistin and indexes of the functional state of the liver in patients with non-alcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (DM) and with...
Non-alcoholic fatty liver disease: features of metabolic changes at different stages of the disease
Background. Non-alcoholic fatty liver disease (NAFLD) is a chronic diffuse liver pathology that includes simple steatosis, non-alcoholic steatohepatitis with the risk of progression to cirrhosis or even hepatocellular ca...